文献速递功能神经外科

全身麻醉下MRI引导的STN脑深部电刺激治疗帕金森病:结果与微毁损效应分析

MRI-guided DBS of STN under general anesthesia for Parkinson's disease: results and microlesion effect analysis.
PubMed 文献 · Acta Neurochir (Wien) · 2022-07-16

该研究回顾性分析2013年10月至2020年12月间32例双侧STN-DBS的帕金森病患者,在全身麻醉下基于术前CT、MRI与术中3D透视融合进行直接定位。术后微毁损效应发生率为90.7%,平均随访17个月,关药开刺激状态下UPDRS III较基线改善64.8%,Prolopa平均剂量减少31.3%,无永久性并发症。

要点

  • 全麻下基于术前CT/MRI与术中3D透视融合直接定位STN安全,无永久性并发症。
  • 术后微毁损效应发生率为90.7%,平均随访17个月UPDRS III关药开刺激状态改善64.8%。
  • 术后Prolopa平均剂量较术前减少31.3%。

核心结论

  • 全麻下基于术前CT和MRI数据融合术中3D透视直接定位STN是安全的,可获得高术后微毁损效应率(90.7%)并带来持续临床改善。

研究设计与样本

  • 回顾性分析2013年10月至2020年12月连续32例全麻下双侧STN-DBS的帕金森病患者,术中使用立体定向机器人3D透视(Artis Zeego,Siemens)与术前CT和MRI数据融合定位。

主要发现

  • 平均手术时间223分钟,无永久性并发症。
  • 微毁损效应发生率为90.7%。
  • 平均随访时间17个月,关药开刺激状态UPDRS III较基线改善64.8%。
  • 术后Prolopa平均剂量减少31.3%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The efficacy of the subthalamic nucleus (STN) stimulation for Parkinson's disease has been widely established. The microlesion effect (MLE) due to deep brain stimulation (DBS) electrode implantation has been reputed to be a good predictor for long-term efficacy of the procedure but its analysis in asleep implantation is still unclear. We thus analyzed MLE rate in our strategy of targeting the STN on MRI under general anesthesia and its correlation with our long-term results. METHOD: We retrospectively analyzed 32 consecutive parkinsonian patients implanted with a DBS targeting the STN bilaterally under general anesthesia between October 2013 and December 2020. Targeting was performed after head frame and localizer placement using a stereotactic peroperative robotic 3D fluoroscopy (Artis Zeego, Siemens) fused with preoperative CT and MRI data. We collected intraoperative data, postoperative occurrence of MLE, modification of Unified Parkinson Disease Rating Scale item III (UPDRS III) postoperatively and at subsequent visit, as well as reduction of medication. RESULTS: The mean operative time was 223 min. No permanent complication occurred. MLE was observed in 90.7%. The mean follow-up time was 17 months. The UPDRS III for the off medication/on stimulation condition improved by 64.8% from baseline. The mean dose reduction of Prolopa after the surgical procedure was 31.3%. CONCLUSIONS: Direct targeting of STN under general anesthesia based on preoperative CT and MRI data fused with a preoperative 3D fluoroscopy is safe. It allows for a high rate of postoperative MLE (90.7%) and results in prolonged clinical improvement.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Soler-Rico M, Peeters JB, Joris V, et al. MRI-guided DBS of STN under general anesthesia for Parkinson's disease: results and microlesion effect analysis. Acta Neurochir (Wien). 2022. PMID: 35841433. doi:10.1007/s00701-022-05302-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。